Cysteine is one of the amino acid residues most frequently exploited in targeted covalent drug discovery. Its side-chain thiol has substantial nucleophilic potential and can form stable covalent bonds with electrophilic groups such as acrylamides. Targeted covalent inhibitors typically first ...
Targeted covalent inhibitors (TCIs) first form a noncovalent complex with the target protein and then form a covalent bond with a specific amino acid residue near the binding pocket. Their development focuses on increasing target occupancy and duration of action while controlling warhead ...